Absci Corp (NAS:ABSI)
$ 3.98 -0.39 (-8.92%) Market Cap: 450.07 Mil Enterprise Value: 302.77 Mil PE Ratio: 0 PB Ratio: 1.87 GF Score: 38/100

Absci Corp at HC Wainwright Investment Conference - New York Transcript

Sep 11, 2023 / 06:00PM GMT
Release Date Price: $1.66 (+1.22%)
Swayampakula Ramakanth
H.C. Wainwright & Co., LLC - Analyst

Good afternoon, and thanks for joining us to have a conversation with Alex Khan, Vice President of Finance and IR of Absci Corporation. Absci is a generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics.

Absci technology has been validated by generating relationships with companies such as Merck and high-tech company such as NVIDIA. The company has established a proprietary drug creation platform and recently has made the decision to spend more of their resources on internal drug development programs while executing on their partnered active programs.

To discuss the company's development strategy in 2023 and beyond, I welcome Alex to this fireside chat. Alex, glad to see you accepting our invitation to talk to our audience today.

Alex Khan
Absci Corporation - VP, Finance and IR

Well, thank you, RK, and thank you, H.C. Wainwright, for the opportunity. Happy to be here.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot